In Albanian In Bulgarian In Macedonian In Romanian In Serbian
By strengthening its position in the markets, consolidating its portfolio and fostering potential, the North Macedonian pharmaceutical company Replec continues to deliver strong results. Year-to-date through September, the company has realized a 44% year-on-year increase in sales revenue in the pharmaceutical sector, BalkanEngineer.com has learned from Denar.mk.
The positive business results registered by the company are due to the growth of sales revenues in the pharmacy segment in foreign markets, which amounted to 52%, and also to the growth in the domestic market, which was 21%, compared to the previous year. This is due to fundamental changes in the company's export strategy and to an internal reorganization based on active innovation and close collaboration between experienced professionals and young specialists with fresh ideas.
The parameters achieved in the third quarter of 2023 are historically the best for the company since its inception.
As much as 82% of Replec's portfolio is marketed externally in more than 20 countries. The company has a presence in the European Union, the Adriatic region, as well as Central and Southeast Asia, with some of the company's pharmaceutical products among the top sellers in certain markets.
Photo source: canva.com